Skip to main navigation Skip to search Skip to main content

Air Discharge Plasma-Activated Hydrosols with Phased RONS-Mediated Anti-Infection, Anti-Inflammation, and Tissue Remodeling Effects for the Integrated Treatment of Chronic Wounds

  • Hao Zhang
  • , Xixi Jing
  • , Zewei Wang
  • , Tong Wu
  • , Chengbiao Ding
  • , Dingxin Liu*
  • , Jishen Zhang
  • , Yuan Zhao
  • , Li Guo
  • , Yumin Xia
  • , Mingzhe Rong
  • , Qian Liu*
  • , Yin Xiao
  • , Xiaolin Zhang
  • , Paul K. Chu*
  • *Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

Abstract

Chronic wound repair requires strategies integrating anti-infection, anti-inflammation, and tissue regeneration across wound healing stages. Nevertheless, few therapeutic approaches can incorporate all of these strategies. Although cold atmospheric plasma can regulate cell physiology and pathology through the generation of reactive oxygen and nitrogen species (RONS) and is promising in wound healing applications, how to store and deliver optimal RONS to chronic wound sites is highly challenging. Herein, the air discharge plasma-activated sodium alginate hydrosol (PAHSA) is used to carry RONS to accomplish integrated chronic wound treatment. In vitro results demonstrate that abundant aqueous RONS are incorporated into PAHSA by gas–liquid reactions between the plasma and sodium alginate hydrosol. PAHSA, boasting promising RONS storage and slow-release properties, shows phased RONS-mediated sterilization, macrophage polarization regulation, and cell migration. Moreover, in the animal model with chronic wound healing, PAHSA reduces bacterial infection through a controlled local inflammatory reaction and promotes growth factor release to stimulate tissue regeneration. Continuous delivery of RONS with gradient concentrations is biocompatible and shows no systemic toxicity. This study demonstrates that the natural decay of plasma-generated RONS can be temporally matched to the dynamic needs of the healing process, underscoring the clinical potential of plasma-activated hydrosols in integrated chronic wound treatment.

© 2026 American Chemical Society
Original languageEnglish
Pages (from-to)16056–16068
Number of pages13
JournalACS Applied Materials & Interfaces
Volume18
Issue number11
Online published16 Mar 2026
DOIs
Publication statusPublished - 25 Mar 2026

Funding

This work was supported by the National Natural Science Foundation of China under Grant Nos. 52277231, Fundamental Research Funds for the Central University, City University of Hong Kong Donation Research Grants (No. DON-RMG 9229021 and No. 9229021), as well as Guangdong–Hong Kong Technology Cooperation Funding Scheme (TCFS GHP/212/22GD and CityU 9440399).

Research Keywords

  • cold atmospheric plasma
  • plasma-activated hydrosols
  • reactive oxygen and nitrogen species
  • chronic wounds
  • integrated therapy

RGC Funding Information

  • RGC-funded

Fingerprint

Dive into the research topics of 'Air Discharge Plasma-Activated Hydrosols with Phased RONS-Mediated Anti-Infection, Anti-Inflammation, and Tissue Remodeling Effects for the Integrated Treatment of Chronic Wounds'. Together they form a unique fingerprint.

Cite this